David Geldmacher, MD
Enriched profileUniversity Professor; Professor, Warren Family Endowed Chair in Neurology; Vice Chair for Clinical Affairs; and Director, Division of Cognitive and Behavioral Neurology, UAB Department of Neurology · University of Alabama at Birmingham
David Geldmacher is University Professor; Professor, Warren Family Endowed Chair in Neurology; Vice Chair for Clinical Affairs; and Director, Division of Cognitive and Behavioral Neurology, UAB Department of Neurology at University of Alabama at Birmingham. OpenAlex indexes 282 publications with 15,180 citations (h-index 56); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 1 Sept 2026
David Geldmacher is University Professor at University of Alabama at Birmingham, Marnix E. Heersink School of Medicine, Department of Neurology. The public record shows 282 publications with 15,180 citations (h-index 56), centered on Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 6 companies, 2 NIH-funded awards (2020–2026).
- Most recent indexed publication: 2026 · The journals of gerontology. Series B, Psychological sciences and social sciences
- Top research focus: Dementia and Cognitive Impairment Research
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 146.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 1 Sept 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
Sponsor: University of Alabama at Birmingham
- Genetic Evaluation for Medication Selection (GEMS) Study
Sponsor: University of Alabama at Birmingham
- Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI
Sponsor: University of Alabama at Birmingham
Industry payments
Updated 1 Sept 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Eisai Inc.Program year20256 payments
- Eli Lilly and CompanyProgram year20252 payments
- F. Hoffmann-La Roche AGProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI34.7%Citalopram Hbr67%Escitalopram Oxalate33%Part D<11 patientsCholinesterase Inhibitor25.6%Donepezil Hcl59%Rivastigmine41%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 1 Sept 2026
2 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
Publications
Updated 1 Sept 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Variations in the effect of pulse pressure on cognition based on blood pressure.
The journals of gerontology. Series B, Psychological sciences and social sciences
Article2026 - Contributions of rare and common variation to early-onset and atypical dementia risk.
Cold Spring Harbor molecular case studies
Article2023 - Cognitive Processing Speed Is Strongly Related to Driving Skills, Financial Abilities, and Other Instrumental Activities of Daily Living in Persons With Mild Cognitive Impairment and Mild Dementia.
The journals of gerontology. Series A, Biological sciences and medical sciences
Article2021
Most-cited works
by citation count (OpenAlex)- 01
- 02Development of Cognitive Instruments for Use in Clinical Trials of Antidementia DrugsArticle708 citations1997
- 03DNA Replication Precedes Neuronal Cell Death in Alzheimer's DiseaseArticle625 citations2001
- 04
- 05
Network
Updated 1 Sept 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 1 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/david-geldmacher-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/uab_neurology/p/CupH1R0rluv
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - X / Twitter
x.com/uabneurores/status/1824119001728852379
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 1 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Fellowship in Behavioral Neurology and Neuropsychology
University of Florida/Shands Hospital, Gainesville, FL
1991
Editorial & leadership roles
journal and society appointmentsAwards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dpo.uab.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →continuumaudio.libsyn.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thealabamabaptist.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham